Skip to content
10-K

Annual Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-15-022873

← back to feed
Filed
Apr 15, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Apr 14, 2015 22.01M sh
Short Term Debt FY 2014 · Dec 31, 2014 $200K
Cash And Equivalents FY 2014 · Dec 31, 2014 $12.51K
Cash And Equivalents FY 2014 · Dec 31, 2013 $44.9K
Cash And Equivalents FY 2014 · Dec 31, 2012 $511.69K
Stockholders Equity FY 2014 · Dec 31, 2014 −$5.66M
Stockholders Equity FY 2014 · Dec 31, 2013 −$3.12M
Stockholders Equity FY 2014 · Dec 31, 2012 −$1.68M
Current Liabilities FY 2014 · Dec 31, 2014 $4.98M
Current Liabilities FY 2014 · Dec 31, 2013 $3.22M
Total Liabilities FY 2014 · Dec 31, 2014 $5.68M
Total Liabilities FY 2014 · Dec 31, 2013 $3.22M
Current Assets FY 2014 · Dec 31, 2014 $12.51K
Current Assets FY 2014 · Dec 31, 2013 $95.84K
Total Assets FY 2014 · Dec 31, 2014 $12.51K
Total Assets FY 2014 · Dec 31, 2013 $96.32K
Sga Expense FY 2014 · Dec 31, 2014 $1.88M
Sga Expense FY 2014 · Dec 31, 2013 $621.63K
Rd Expense FY 2014 · Dec 31, 2014 $669.41K
Rd Expense FY 2014 · Dec 31, 2013 $900.56K
Net Income FY 2014 · Dec 31, 2014 −$2.54M
Net Income FY 2014 · Dec 31, 2013 −$1.45M
Operating Income FY 2014 · Dec 31, 2014 −$2.55M
Operating Income FY 2014 · Dec 31, 2013 −$1.52M
Revenue FY 2014 · Dec 31, 2014 $0
Revenue FY 2014 · Dec 31, 2013 $0